---

Dr. Jennifer Kent partners with clients to provide strategic insight and execution of a variety of projects, including publication plans, publication development, retrospective analyses, meeting summaries, internal white papers, and competitive surveillance reports in the areas of hematology/oncology, oncology supportive care, women’s health, gastrointestinal disorders, men’s health, and Parkinson disease. She has also been involved in management of various regulatory projects, including study protocols, protocol amendments, briefing documents, pediatric study plans, investigator brochures, and NDA submission documents. Additionally, Jennifer works with clients, physicians, and other health care professionals to manage and develop content for advisory boards targeted to different audiences, including leading oncologists, oncology nurses, and pharmacy directors covering a variety of therapeutic areas such as breast cancer, management of chemotherapy-induced nausea and vomiting, glioblastoma, management of mucositis, multiple myeloma, non-small cell lung cancer, prostate cancer, ovarian cancer, and management of venous thromboembolism.

Jennifer has experience in researching and creating primary and secondary peer-reviewed articles; abstracts, posters, and slides for major medical meetings; and various other written materials such as retrospective analyses, registry reports, meeting summaries, internal white papers, competitive surveillance reports, and educational programs in manuscript or slide format. Areas in which she has written include management of type 2 diabetes, sleep research, erectile dysfunction, tissue disorders such as Peyronie’s disease and Dupuytren’s contracture, and hematology/oncology—specifically, breast cancer, myelodysplastic syndrome, acute myeloid leukemia, management of chemotherapy-induced nausea and vomiting, metastatic liver cancer, prostate cancer, and management of venous thromboembolism.

Prior to joining MedVal, Jennifer was a post-doctoral fellow with Dr. Nigel Fraser at the University of Pennsylvania in the Department of Microbiology. While in Dr. Fraser’s laboratory, Jennifer studied the regulation of gene expression of herpes simplex virus type 1 during the lytic and latent phases of infection. Several abstracts and articles from this research were presented at local and international virology meetings and were published in peer-reviewed journals such as the Journal of Virology and the Journal of Neurovirology.

Jennifer earned her Bachelor of Arts degree in Biology from Wittenberg University. She went on to receive her PhD from the University of Delaware, where her dissertation involved research on the impact of recombinant vaccines against an avian oncogenic herpesvirus.